| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
1 Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York; 2 Veterinary Pathology Section, Pathology/Histotechnology Laboratory, Science Applications International Corporation, National Cancer Institute, NIH, Frederick, Maryland; 3 Department of Biomedical Sciences, Tufts University School of Veterinary Medicine, North Grafton, Massachusetts; 4 Center for Comparative Medicine, University of California, Davis, California; 5 Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; 6 Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts; 7 Departments of Pathology and Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 8 Department of Pathology, Medical College of Ohio, Toledo, Ohio; 9 Department of Anatomy, Edinburgh University, Edinburgh, United Kingdom; 10 Cell and Cancer Biology Department, Center for Cancer Research, National Cancer Institute, NIH, Rockville, Maryland; 11 National Cancer Institute, NIH, Bethesda, Maryland; 12 Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; 13 GlaxoSmithKline, King of Prussia, Pennsylvania; 14 Department of Pathology and Laboratory Medicine, The David Geffen School of Medicine, University of California, Los Angeles, California; 15 Department of Pathology, Experimental Oncology Laboratory; College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee; 16 Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC; 17 Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland; and 18 Department of Biology, Massachusetts Institute of Technology and Howard Hughes Medical Institute, Center for Cancer Research, Cambridge, Massachusetts
Rapid advances in generating new mouse genetic models for lung neoplasia provide a continuous challenge for pathologists and investigators. Frequently, phenotypes of new models either have no precedents or are arbitrarily attributed according to incongruent human and mouse classifications. Thus, comparative characterization and validation of novel models can be difficult. To address these issues, a series of discussions was initiated by a panel of human, veterinary, and experimental pathologists during the Mouse Models of Human Cancers Consortium (NIH/National Cancer Institute) workshop on mouse models of lung cancer held in Boston on June 2022, 2001. The panel performed a comparative evaluation of 78 cases of mouse and human lung proliferative lesions, and recommended development of a new practical classification scheme that would (a) allow easier comparison between human and mouse lung neoplasms, (b) accommodate newly emerging mouse neoplasms, and (c) address the interpretation of benign and preinvasive lesions of the mouse lung. Subsequent discussions with additional experts in pulmonary pathology resulted in the current proposal of a new classification. It is anticipated that this classification, as well as the complementary digital atlas of virtual histological slides, will help investigators and pathologists in their characterization of new mouse models, as well as stimulate further research aimed at a better understanding of proliferative lesions of the lung.
This article has been cited by other articles:
![]() |
H. M. Schuller, H. A.N. Al-Wadei, and M. Majidi Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma Carcinogenesis, October 1, 2008; 29(10): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kassie, I. Matise, M. Negia, D. Lahti, Y. Pan, R. Scherber, P. Upadhyaya, and S. S. Hecht Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen-Induced Lung Adenocarcinoma in Mice Cancer Prevention Research, September 1, 2008; 1(4): 285 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. A. van den Brand, B. L. Haagmans, L. Leijten, D. van Riel, B. E. E. Martina, A. D. M. E. Osterhaus, and T. Kuiken Pathology of Experimental SARS Coronavirus Infection in Cats and Ferrets Vet. Pathol., July 1, 2008; 45(4): 551 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. L. Hong, T.-V. T. Ton, Y. Kim, N. Wakamatsu, N. P. Clayton, P.-C. Chan, R. C. Sills, and S. A. Lahousse Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene Toxicol Pathol, July 1, 2008; 36(5): 720 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Larsen, L. Kleppa, T. J. Meza, L. A. Meza-Zepeda, C. Rada, C. G. Castellanos, G. F. Lien, G. J. Nesse, M. S. Neuberger, J. K. Laerdahl, et al. Early-Onset Lymphoma and Extensive Embryonic Apoptosis in Two Domain-Specific Fen1 Mice Mutants Cancer Res., June 15, 2008; 68(12): 4571 - 4579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dixon, R. A. Herbert, G. E. Kissling, A. E. Brix, R. A. Miller, and R. R. Maronpot Summary of Chemically Induced Pulmonary Lesions in the National Toxicology Program (NTP) Toxicology and Carcinogenesis Studies Toxicol Pathol, April 1, 2008; 36(3): 428 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwanaga, Y. Yang, M. G. Raso, L. Ma, A. E. Hanna, N. Thilaganathan, S. Moghaddam, C. M. Evans, H. Li, W.-W. Cai, et al. Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer Cancer Res., February 15, 2008; 68(4): 1119 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pandey, S. M. Umphress, Y. Kang, J. Angdisen, A. Naumova, K. L. Mercer, T. Jacks, and S. B. Jakowlew Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- 1 haploinsufficiency Carcinogenesis, December 1, 2007; 28(12): 2589 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Tao, J. Fujimoto, T. Men, X. Ye, J. Deng, L. Lacroix, J. L. Clifford, L. Mao, C. S. Van Pelt, J. J. Lee, et al. Identification of the Retinoic Acid Inducible Gprc5a As a New Lung Tumor Suppressor Gene J Natl Cancer Inst, November 21, 2007; 99(22): 1668 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lian, D. E. Smith, H. Ernst, R. M. Russell, and X.-D. Wang Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo Carcinogenesis, July 1, 2007; 28(7): 1567 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kunder, J. Calzada-Wack, G. Holzlwimmer, J. Muller, C. Kloss, W. Howat, J. Schmidt, H. Hofler, M. Warren, and L. Quintanilla-Martinez A Comprehensive Antibody Panel for Immunohistochemical Analysis of Formalin-Fixed, Paraffin-Embedded Hematopoietic Neoplasms of Mice: Analysis of Mouse Specific and Human Antibodies Cross-Reactive with Murine Tissue Toxicol Pathol, April 1, 2007; 35(3): 366 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Pei, F. Bai, M. D. Smith, and Y. Xiong p18Ink4c Collaborates with Men1 to Constrain Lung Stem Cell Expansion and Suppress Non-Small-Cell Lung Cancers Cancer Res., April 1, 2007; 67(7): 3162 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dankort, E. Filenova, M. Collado, M. Serrano, K. Jones, and M. McMahon A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors Genes & Dev., February 15, 2007; 21(4): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wakamatsu, T. R. devereux, H.-H. L. Hong, and R. C. Sills Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer Toxicol Pathol, January 1, 2007; 35(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Hahn, A. Gigliotti, and J. A. Hutt Comparative Oncology of Lung Tumors Toxicol Pathol, January 1, 2007; 35(1): 130 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lu, J. Liao, G. Yang, K. R. Reuhl, X. Hao, and C. S. Yang Inhibition of Adenoma Progression to Adenocarcinoma in a 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Lung Tumorigenesis Model in A/J Mice by Tea Polyphenols and Caffeine Cancer Res., December 1, 2006; 66(23): 11494 - 11501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, R. Mahmood, R. Hnasko, and J. Locker Loss of Nkx2.8 Deregulates Progenitor Cells in the Large Airways and Leads to Dysplasia Cancer Res., November 1, 2006; 66(21): 10399 - 10407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cardiff, M. R. Anver, G. P. Boivin, M. W. Bosenberg, R. R. Maronpot, A. A. Molinolo, A. Y. Nikitin, J. E. Rehg, G. V. Thomas, R. G. Russell, et al. Precancer in Mice: Animal Models Used to Understand, Prevent, and Treat Human Precancers Toxicol Pathol, October 1, 2006; 34(6): 699 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucattelli, S. Fineschi, P. Geppetti, N. P. Gerard, and G. Lungarella Neurokinin-1 Receptor Blockade and Murine Lung Tumorigenesis Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 674 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, T. Wakai, Y. Shirai, K. Hatakeyama, and S. Hirano Chronic Oral Exposure to Inorganic Arsenate Interferes with Methylation Status of p16INK4a and RASSF1A and Induces Lung Cancer in A/J Mice Toxicol. Sci., June 1, 2006; 91(2): 372 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ji, X. Zhao, Y. Yuza, T. Shimamura, D. Li, A. Protopopov, B. L. Jung, K. McNamara, H. Xia, K. A. Glatt, et al. Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors PNAS, May 16, 2006; 103(20): 7817 - 7822. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Stearman, L. Dwyer-Nield, L. Zerbe, S. A. Blaine, Z. Chan, P. A. Bunn Jr., G. L. Johnson, F. R. Hirsch, D. T. Merrick, W. A. Franklin, et al. Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model Am. J. Pathol., December 1, 2005; 167(6): 1763 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Floyd, C. L. Farnsworth, N. D. Kock, M. C. Mizesko, J. L. Little, S. T. Dance, J. Everitt, J. Tichelaar, J. A. Whitsett, and M. S. Miller Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model Carcinogenesis, December 1, 2005; 26(12): 2196 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hutt, B. R. Vuillemenot, E. B. Barr, M. J. Grimes, F. F. Hahn, C. H. Hobbs, T. H. March, A. P. Gigliotti, S. K. Seilkop, G. L. Finch, et al. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways Carcinogenesis, November 1, 2005; 26(11): 1999 - 2009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hollander, R. T. Philburn, A. D. Patterson, S. Velasco-Miguel, E. C. Friedberg, R. I. Linnoila, and A. J. Fornace Jr. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis PNAS, September 13, 2005; 102(37): 13200 - 13205. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zanesi, R. Mancini, C. Sevignani, A. Vecchione, M. Kaou, M. Valtieri, G. A. Calin, Y. Pekarsky, J. R. Gnarra, C. M. Croce, et al. Lung Cancer Susceptibility in Fhit-Deficient Mice Is Increased by Vhl Haploinsufficiency Cancer Res., August 1, 2005; 65(15): 6576 - 6582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, M. L. Spencer, J. G. Izzo, D. M. Juroske, K. Balhara, D. D. Cody, R. E. Price, W. N. Hittelman, I. I. Wistuba, and J. M. Kurie Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras Cancer Res., April 15, 2005; 65(8): 3226 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meuwissen and A. Berns Mouse models for human lung cancer Genes & Dev., March 15, 2005; 19(6): 643 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, D. Bellgrau, L. D. Dwyer-Nield, A. M. Malkinson, R. C. Duke, T. C. Rodell, and A. Franzusoff Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy Cancer Res., August 1, 2004; 64(15): 5084 - 5088. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |